Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04859933
Status:
COMPLETED
Last Update Posted:
2022-08-09
First Post:
2021-04-22
Brief Title:
AV Node Isolation in Atrial Fibrillation vs Modulation by Pace and Ablate Strategy
Sponsor:
Heart and Diabetes Center North-Rhine Westfalia
Organization:
Heart and Diabetes Center North-Rhine Westfalia
Study Overview
Official Title:
AV Node Isolation in Atrial Fibrillation vs Modulation by Pace and Ablate Strategy
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
AV-node ablation AVNA is a common therapy option for rate control strategy of permanent atrial fibrillation with numerous side effects The investigators hypothesised that an isolation of the AV node is concomitant with less occurrence of new bundle brunch blocks more frequent preservation and higher rate of escape rhythm compared to AVNA This retrospective study includes 20 patients being treated with AV-node isolation AVNI and 40 historical AVNA-controls Among others these two methods were compared regarding escape rhythm delta QRS procedure time ablation points fluoroscopy time and total dose area product DAP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None